glutathione and triple negative breast cancer Frontiers Glutathione-depleting self-immolative nanoparticles boost cuproptosis-driven
Glutathione depleting self immolative nanoparticles boost cuproptosis driven metalloimmunotherapy for triple negative breast cancer Journal of Nanobiotechnology Springer Nature Link Oncology Letters GPX4 in triple negative breast cancer: A key regulator of ferroptosis and therapeutic target ScienceDirect A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect CD36 enhances sensitivity of triple negative breast cancer cells to palmitate induced ferroptosis Cell Death & Disease Glutathione peroxidase 4 (GPX4) and obesity interact to impact tumor progression and treatment response in triple negative breast cancer Cancer & Metabolism Springer Nature Link
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7





